Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective.
about
Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrantSystemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesPhase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trialEtirinotecan pegol for the treatment of breast cancer.Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors.
P2860
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Second International Consensus ...... /2013: The German Perspective.
@ast
Second International Consensus ...... /2013: The German Perspective.
@en
type
label
Second International Consensus ...... /2013: The German Perspective.
@ast
Second International Consensus ...... /2013: The German Perspective.
@en
prefLabel
Second International Consensus ...... /2013: The German Perspective.
@ast
Second International Consensus ...... /2013: The German Perspective.
@en
P2093
P2860
P50
P356
P1433
P1476
Second International Consensus ...... /2013: The German Perspective.
@en
P2093
Anton Scharl
Christian Jackisch
Christoph Thomssen
Hans Tesch
Hans-Joachim Lück
Norbert Marschner
Rachel Wuerstlein
Susanna Hegewisch-Becker
Thomas Decker
P2860
P356
10.1159/000358689
P50
P577
2014-02-01T00:00:00Z